Issue 5/2013
Content (10 Articles)
Invited Commentary
Ovarian Cancer Survival: Steady Improvement, Despite Rhetoric to the Contrary
Maurie Markman
Leukemia (A Aguayo, Section Editor)
Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: To Whom, When, and How
John Magenau, Daniel R. Couriel
Leukemia (A Aguayo, Section Editor)
Acute Promyelocytic Leukemia: Do We Have a New Front-Line Standard of Treatment?
Miguel A. Sanz, Gloria Iacoboni, Pau Montesinos
Lymphomas (PA Hamlin, Section Editor)
Genetic Factors and Pathogenesis of Waldenström’s Macroglobulinemia
Jorge Monge, Esteban Braggio, Stephen M. Ansell
Lymphomas (PA Hamlin, Section Editor)
Therapeutic Options for Adult T-Cell Leukemia/Lymphoma
Ambroise Marçais, Felipe Suarez, David Sibon, Laurent Frenzel, Olivier Hermine, Ali Bazarbachi
Melanoma (KB Kim, Section Editor)
Current Treatment of Locoregional Recurrence of Melanoma
Malcolm Hart Squires III, Keith A. Delman
Melanoma (KB Kim, Section Editor)
MEK Inhibition in the Treatment of Advanced Melanoma
April K. S. Salama, Kevin B. Kim
Melanoma (KB Kim, Section Editor)
Melanoma Brain Metastases: an Unmet Challenge in the Era of Active Therapy
Vikram Gorantla, John M. Kirkwood, Hussein A. Tawbi
Melanoma (KB Kim, Section Editor)
Inhibition of Angiogenesis for the Treatment of Metastatic Melanoma
Aaron S. Mansfield, Svetomir N. Markovic
Melanoma (KB Kim, Section Editor)
Checkpoint Modulation in Melanoma: An Update on Ipilimumab and Future Directions
David B. Page, Michael A. Postow, Margaret K. Callahan, Jedd D. Wolchok